![Christina Trojel-Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Christina Trojel-Hansen is the founder of Oscine Corp.
She previously worked as a Senior Associate at Novo Seeds from 2016 to 2018.
Ehemalige bekannte Positionen von Christina Trojel-Hansen
Unternehmen | Position | Ende |
---|---|---|
Oscine Corp.
![]() Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Vorstandsvorsitzender | 01.09.2020 |
Novo Seeds
![]() Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Private-Equity-Analyst | 01.04.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Novo Seeds
![]() Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Finance |
Oscine Corp.
![]() Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Health Technology |